Skip to main content
. 2022 Dec 9;71(49):1560–1564. doi: 10.15585/mmwr.mm7149a5

FIGURE.

The figure is a line graph showing the weekly monkeypox (mpox) incidence among vaccine-eligible men aged 18–49 years in 43 U.S. jurisdictions, by vaccination status during July 31–October 1, 2022.

Weekly mpox incidence* among vaccine-eligible† men aged 18–49 years, by vaccination status§ — 43 U.S. jurisdictions,,** July 31–October 1, 2022

Abbreviation: IRR = incidence rate ratio.

* Cases per 100,000 population. Rate in vaccinated persons = number of probable or confirmed cases reported to CDC with date of illness onset, specimen collection, lab test completion, admission, diagnosis, discharge, case investigation start date, or date first electronically submitted or reported to the county, state, or public health department (earliest available date) ≥14 days after receiving dose 1 or dose 2 of JYNNEOS vaccine among total vaccinated population as of 2 weeks previously. Rate in unvaccinated persons = number of probable or confirmed cases reported to CDC without evidence of vaccination among total unvaccinated population.

† Gay, bisexual, and other men who have sex with men who have HIV infection or who are eligible to receive HIV preexposure prophylaxis were considered eligible for vaccination.

§ IRR comparing unvaccinated persons with those who received only 1 dose of vaccine ≥14 days earlier was 7.4. IRR comparing unvaccinated persons with those who received dose 2 of vaccine ≥14 days earlier was 9.6.

Alabama, Alaska, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Mexico, New York (excluding New York City), North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, Virginia, West Virginia, Wisconsin, and Wyoming.

** Jurisdictions were included if age and sex assigned at birth or gender identity was available for ≥70% of cases reported, vaccination status was available for ≥50% of cases, or jurisdiction-confirmed cases were linked to immunization registry entries, and deidentified vaccination administration data were submitted to CDC.